Dual Antiplatelet Therapy for High-Risk TIA and Minor Stroke: BMJ Rapid Recommendation

被引:0
|
作者
Croke, Lisa
机构
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:378 / 379
页数:2
相关论文
共 50 条
  • [1] Dual antiplatelet therapy in high risk patients with TIA or minor stroke
    Rodriguez Jorge, F.
    Garcia-Madrona, S.
    De Felipe Mimbrera, A.
    Cruz Culebras, A.
    Beltran Corbellini, A.
    Chico Garcia, J. L.
    Parra Diaz, P.
    Gomez Lopez, A.
    Sanchez Sanchez, A.
    Baena Alvarez, B.
    Matute Lozano, C.
    Vera Lechuga, R.
    Masjuan Vallejo, J.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 590 - 590
  • [2] European Stroke Organisation expedited recommendation for the use of short-term dual antiplatelet therapy early after minor stroke and high-risk TIA
    Dawson, Jesse
    Merwick, Aine
    Webb, Alastair
    Dennis, Martin
    Ferrari, Julia
    Fonseca, Ana Catarina
    [J]. EUROPEAN STROKE JOURNAL, 2021, 6 (02) : CLXXXVII - CXCI
  • [3] Guideline: Starting dual antiplatelet therapy ≤ 24 h after high-risk TIA or minor ischemic stroke is recommended
    Uchino, Ken
    [J]. ANNALS OF INTERNAL MEDICINE, 2019, 170 (08) : JC38 - JC38
  • [4] Treating High-Risk TIA and Minor Stroke Patients With Dual Antiplatelet Therapy: A National Survey of Emergency Medicine Physicians
    Liberman, Ava L.
    Lendaris, Andrea R.
    Cheng, Natalie T.
    Kaban, Nicole L.
    Rostanski, Sara K.
    Esenwa, Charles
    Kummer, Benjamin R.
    Labovitz, Daniel L.
    Prabhakaran, Shyam
    Friedman, Benjamin W.
    [J]. NEUROHOSPITALIST, 2022, 12 (01): : 13 - 18
  • [5] Is Dual Antiplatelet Therapy Underutilized Following TIA and Minor Stroke?
    Solomonow, Jonathan
    Marks, Jamie
    Yarbrough, Karen
    Mehndiratta, Prachi
    Chaturvedi, Seemant
    [J]. NEUROLOGY, 2023, 100 (17)
  • [6] Is Dual Antiplatelet Therapy Underutilized Following TIA And Minor Stroke?
    Solomonow, Jonathan
    Marks, Jamie R.
    Yarbrough, Karen L.
    Mehndiratta, Prachi
    Chaturvedi, Seemant
    [J]. STROKE, 2023, 54
  • [7] Risk factors associated with 90-day recurrent stroke in patients on dual antiplatelet therapy for minor stroke or high-risk TIA: a subgroup analysis of the CHANCE trial
    Wangqin, Runqi
    Wang, Xianwei
    Wang, Yilong
    Xian, Ying
    Zhao, Xingquan
    Liu, Liping
    Li, Hao
    Meng, Xia
    Wang, Yongjun
    [J]. STROKE AND VASCULAR NEUROLOGY, 2017, 2 (04) : 176 - 183
  • [8] Extending Dual Antiplatelet Therapy for TIA or Stroke
    Kim, Anthony S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (26): : 2478 - 2479
  • [9] Dual Antiplatelet Therapy for Minor Stroke and High-Risk Transient Ischemic Attack What Have We Learned?
    Liu, Liping
    Dowlatshahi, Dariush
    [J]. STROKE, 2018, 49 (09) : 2278 - 2279
  • [10] Is clopidogrel the antiplatelet drug of choice for high-risk patients with stroke/TIA?: No
    Hankey, GJ
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (06) : 1137 - 1140